148 related articles for article (PubMed ID: 1652143)
1. Role of central versus peripheral opioid receptors in analgesia induced by repeated administration of opioid antagonists.
Walker MJ; Lê AD; Poulos CX; Cappell H
Psychopharmacology (Berl); 1991; 104(2):164-6. PubMed ID: 1652143
[TBL] [Abstract][Full Text] [Related]
2. Chronic selective blockade of mu opioid receptors produces analgesia and augmentation of the effects of a kappa agonist.
Walker MJ; Lê AD; Poulos CX; Cappell H
Brain Res; 1991 Jan; 538(2):181-6. PubMed ID: 1849435
[TBL] [Abstract][Full Text] [Related]
3. Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphine.
Calcagnetti DJ; Holtzman SG
Pharmacol Biochem Behav; 1991 Jan; 38(1):185-90. PubMed ID: 2017444
[TBL] [Abstract][Full Text] [Related]
4. Quaternary naltrexone reveals the central mediation of conditional opioid analgesia.
Calcagnetti DJ; Helmstetter FJ; Fanselow MS
Pharmacol Biochem Behav; 1987 Jul; 27(3):529-31. PubMed ID: 2821555
[TBL] [Abstract][Full Text] [Related]
5. Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated.
Bals-Kubik R; Herz A; Shippenberg TS
Psychopharmacology (Berl); 1989; 98(2):203-6. PubMed ID: 2569217
[TBL] [Abstract][Full Text] [Related]
6. Reduction of learned helplessness by central administration of quaternary naltrexone.
Blustein JE; Whitehouse WG; Calcagnetti DJ; Troisi JR; Margules DL; Bersh PJ
Physiol Behav; 1992 May; 51(5):1075-8. PubMed ID: 1319586
[TBL] [Abstract][Full Text] [Related]
7. A peripheral, intracerebral, or intrathecal administration of an opioid receptor antagonist blocks illness-induced hyperalgesia in the rat.
McNally GP; Johnston IN; Westbrook RF
Behav Neurosci; 2000 Dec; 114(6):1183-90. PubMed ID: 11142650
[TBL] [Abstract][Full Text] [Related]
8. Naloxone-induced analgesia in diabetic mice.
Kamei J; Kawashima N; Kasuya Y
Eur J Pharmacol; 1992 Jan; 210(3):339-41. PubMed ID: 1319338
[TBL] [Abstract][Full Text] [Related]
9. Effects of opiate antagonists and their quaternary analogues on nucleus accumbens self-stimulation.
Trujillo KA; Belluzzi JD; Stein L
Behav Brain Res; 1989 Jun; 33(2):181-8. PubMed ID: 2548531
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the involvement of central opioidergic systems in L-tyrosine methyl ester-induced analgesia in the rat.
Ramarao P; Bhargava HN
Pharmacology; 1988; 37(1):1-7. PubMed ID: 3420162
[TBL] [Abstract][Full Text] [Related]
11. Naltrexone in vivo protects mu receptors from inactivation by beta-funaltrexamine, but not kappa receptors from inactivation by nor-binaltorphimine.
Paronis CA; Waddell AB; Holtzman SG
Pharmacol Biochem Behav; 1993 Dec; 46(4):813-7. PubMed ID: 8309960
[TBL] [Abstract][Full Text] [Related]
12. Systemic administration of (Tyr-D-Ser(O-tert-butyl)-Gly-Phe-Leu-Thr(O-tert-butyl), a highly selective delta opioid agonist, induces mu receptor-mediated analgesia in mice.
Baamonde A; Daugé V; Gacel G; Roques BP
J Pharmacol Exp Ther; 1991 May; 257(2):767-73. PubMed ID: 1851837
[TBL] [Abstract][Full Text] [Related]
13. Interaction between opioid antagonists and amphetamine: evidence for mediation by central delta opioid receptors.
Jones DN; Holtzman SG
J Pharmacol Exp Ther; 1992 Aug; 262(2):638-45. PubMed ID: 1323656
[TBL] [Abstract][Full Text] [Related]
14. Independent central and peripheral mediation of morphine-induced inhibition of gastrointestinal transit in rats.
Gmerek DE; Cowan A; Woods JH
J Pharmacol Exp Ther; 1986 Jan; 236(1):8-13. PubMed ID: 3941402
[TBL] [Abstract][Full Text] [Related]
15. Blockade of mu-opioid receptors reveals the hyperalgesic effect of orphanin FQ/nociceptin in the rat hot plate test.
Lutfy K; Maidment NT
Br J Pharmacol; 2000 Dec; 131(8):1684-8. PubMed ID: 11139447
[TBL] [Abstract][Full Text] [Related]
16. Central, stereoselective receptors mediate the acute effects of opiate antagonists on luteinizing hormone secretion.
Blank MS; Mann DR; Daugherty DT; Sridiran R; Murphy JR
Life Sci; 1986 Oct; 39(17):1493-99. PubMed ID: 3020332
[TBL] [Abstract][Full Text] [Related]
17. Some effects of the opioid antagonist, naloxone, upon the rat's reactions to a heat stressor.
Westbrook RF; Greeley JD
Q J Exp Psychol B; 1990 Feb; 42(1):1-40. PubMed ID: 2158122
[TBL] [Abstract][Full Text] [Related]
18. Chronic opioid antagonist treatment facilitates nonopioid, stress-induced analgesia.
Yoburn BC; Truesdell LS; Kest B; Inturrisi CE; Bodnar RJ
Pharmacol Biochem Behav; 1987 Jul; 27(3):525-7. PubMed ID: 2821554
[TBL] [Abstract][Full Text] [Related]
19. "Paradoxical" analgesia induced by naloxone and naltrexone.
Greeley JD; Lê AD; Poulos CX; Cappell H
Psychopharmacology (Berl); 1988; 96(1):36-9. PubMed ID: 3147475
[TBL] [Abstract][Full Text] [Related]
20. Effects of naltrindole and nor-binaltorphimine treatment on antinociception induced by sub-acute selective mu opioid receptor blockade.
Walker MJ; Le AD; Poulos CX
Brain Res; 1992 Dec; 599(2):204-8. PubMed ID: 1337857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
